"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 70: | Line 70: | ||
<span style="color: black;">'''Mise en application'''</span> | <span style="color: black;">'''Mise en application'''</span> | ||
[[Team:SupBiotech-Paris/Ciblage Tissulaire#drapeau|Ciblage Tissulaire]] | [[Team:SupBiotech-Paris/Ciblage Tissulaire#drapeau|Ciblage Tissulaire]] | ||
| - | [[Team:SupBiotech-Paris/Ciblage Cellulaire#drapeau| | + | [[Team:SupBiotech-Paris/Ciblage Cellulaire#drapeau|Action antitumorale]] |
| - | [[Team:SupBiotech-Paris/ModificationFr#drapeau| | + | [[Team:SupBiotech-Paris/ModificationFr#drapeau|Modélisation du traitement]] |
[[Team:SupBiotech-Paris/Conclusion3Fr#drapeau|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion3Fr#drapeau|Conclusion]] | ||
Revision as of 16:40, 17 October 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modélisation du traitement Conclusion
Ressources
Biobricks Matériel & Méthode Bibliographie
Ethique & sûreté
